OXAZEPAM (OXAZEPAM)
- Alcohol withdrawal syndrome
- Anxiety
10 mg capsule
- 1 capsule (10 mg) by oral route 3 times per day
15 mg capsule
- 1 capsule (15 mg) by oral route 3 times per day
30 mg capsule
- 1 capsule (30 mg) by oral route 3 times per day
Alcohol withdrawal syndrome
- 1 capsule (15 mg) by oral route 4 times per day
- 1 capsule (15 mg) by oral route 3 times per day
- 2 capsules (20 mg) by oral route 3 times per day
- 2 capsules (20 mg) by oral route 4 times per day
- 1 capsule (30 mg) by oral route 4 times per day
- 2 capsules (30 mg) by oral route 3 times per day
- 2 capsules (30 mg) by oral route 4 times per day
- 1 capsule (30 mg) by oral route 3 times per day
Anxiety
- 1 capsule (10 mg) by oral route 3 times per day
- 1 capsule (10 mg) by oral route 4 times per day
- 1 capsule (15 mg) by oral route 4 times per day
- 1 capsule (15 mg) by oral route 3 times per day
- 2 capsules (20 mg) by oral route 3 times per day
- 2 capsules (20 mg) by oral route 4 times per day
- 1 capsule (30 mg) by oral route 4 times per day
- 2 capsules (30 mg) by oral route 3 times per day
- 2 capsules (30 mg) by oral route 4 times per day
- 1 capsule (30 mg) by oral route 3 times per day
- sodium oxybate
- Xyrem
Contraindicated
- clozapine
- Clozaril
- Dehydrated Alcohol
- ethanol (ethyl alcohol)
- ethyl alcohol-herbal drugs
- Fazaclo
- Lydia Pinkham Herbal
- Versacloz
Severe
Moderate
- buprenorphine-naloxone
- Suboxone
- Zubsolv
- Alcohol intoxication
- Pregnancy
- Shock
Contraindicated
- Borderline personality disorder
- Coma
- Depression
- Drug abuse
- Psychotic disorder
- Pulmonary disease
- Respiratory depression
- Sleep apnea
- Suicidal ideation
Severe
Moderate
- Complex sleep behavior
- Disease of liver
- Hypoalbuminemia
- Hypotension
- Kidney disease with reduction in GFR
- Porphyria
OXAZEPAM (OXAZEPAM)
- Alcohol withdrawal syndrome
- Anxiety
- Muscle weakness
- Ataxia
- Dizziness
- Drowsy
- Dyspepsia
- Slurred speech
More Frequent
Severe
Less Severe
- Acute confusion
- Behavioral disorders
- CNS depression
- Diarrhea
- Fatigue
- General weakness
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Accidental fall
- Agranulocytosis
- Anaphylaxis
- Anemia
- Angioedema
- Aplastic anemia
- Apnea
- Coma
- Dehydration
- Depression
- Disease of liver
- Drug-induced psychosis
- Eosinophilia
- Hallucinations
- Hemolytic anemia
- Hepatomegaly
- Hostility
- Hypotension
- Jaundice
- Leukocytosis
- Leukopenia
- Manic disorder
- Memory impairment
- Neutropenic disorder
- Respiratory depression
- Seizure disorder
- Skin rash
- Sleep walking disorder
- Suicidal ideation
- Thrombocytopenic disorder
- Urinary retention
Less Severe
- Aggressive behavior
- Agitation
- Alopecia
- Anorexia
- Aphonia
- Blurred vision
- Bronchial congestion
- Complex sleep behavior
- Concentration difficulty
- Conjunctivitis
- Constipation
- Contact dermatitis
- Cramps
- Delirium
- Depersonalization
- Diplopia
- Disturbance in thinking
- Dream disorder
- Drug dependence
- Dry eye
- Dry skin
- Dysarthria
- Dyspnea
- Dysuria
- Excitement
- Eyes vertical deviation
- Facial edema
- Gastritis
- Gingival pain
- Glossitis
- Headache disorder
- Hiccups
- Hirsutism
- Increased appetite
- Irritability
- Libido changes
- Loss of taste
- Lymphadenopathy
- Menstrual disorder
- Myalgias
- Nausea
- Nervousness
- Nightmares
- Nocturia
- Nystagmus
- Orthostatic hypotension
- Palpitations
- Paranoid disorder
- Polydipsia
- Pruritus of skin
- Rhinorrhea
- Sialorrhea
- Sleep disorder
- Sneezing
- Sore tongue
- Stomatitis
- Swelling of ankles or feet
- Syncope
- Tachycardia
- Tremor
- Urinary incontinence
- Urine discoloration
- Vertigo
- Visual changes
- Visual field defect
- Vomiting
- Weight gain
- Weight loss
- Xerostomia
- Yawning
Contraindicated
None
Severe Precaution
Oxazepam
Increased CNS effects (prolonged in neonates).
- 1 Day – 29 Days
- Increased CNS effects (prolonged in neonates).
Management or Monitoring Precaution
None
Oxazepam
- Severity Level:
1
- Additional Notes: No fda category; may be assoc. with increased risk of malformations
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Oxazepam
Effect unknown, may be of concern;Possible sedation
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Effect unknown, may be of concern;Possible sedation |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Oxazepam
Neuro/Psych-Increased risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes. General-Shorter-acting benzodiazepines are not safer than longer-acting ones. If used, limit dose to 30mg/day. Use may be appropriate in select indications including severe generalized anxiety disorder or alcohol withdrawal.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- Taking oxazepam with opioid medications (such as codeine, hydrocodone) may increase your risk of very serious side effects, including death. To lower your risk, your doctor should have you take the smallest dose of oxazepam that works, and take it for the shortest possible time. Get medical help right away if any of these very serious side effects occur: slow/shallow breathing, unusual lightheadedness, severe drowsiness/dizziness, difficulty waking up.
Alcohol withdrawal syndrome | |
F10.23 | Alcohol dependence with withdrawal |
F10.230 | Alcohol dependence with withdrawal, uncomplicated |
F10.231 | Alcohol dependence with withdrawal delirium |
F10.232 | Alcohol dependence with withdrawal with perceptual disturbance |
F10.239 | Alcohol dependence with withdrawal, unspecified |
Anxiety | |
F06.4 | Anxiety disorder due to known physiological condition |
F10.180 | Alcohol abuse with alcohol-induced anxiety disorder |
F10.280 | Alcohol dependence with alcohol-induced anxiety disorder |
F10.980 | Alcohol use, unspecified with alcohol-induced anxiety disorder |
F12.180 | Cannabis abuse with cannabis-induced anxiety disorder |
F12.280 | Cannabis dependence with cannabis-induced anxiety disorder |
F12.980 | Cannabis use, unspecified with anxiety disorder |
F14.180 | Cocaine abuse with cocaine-induced anxiety disorder |
F14.280 | Cocaine dependence with cocaine-induced anxiety disorder |
F14.980 | Cocaine use, unspecified with cocaine-induced anxiety disorder |
F15.180 | Other stimulant abuse with stimulant-induced anxiety disorder |
F15.280 | Other stimulant dependence with stimulant-induced anxiety disorder |
F15.980 | Other stimulant use, unspecified with stimulant-induced anxiety disorder |
F16.180 | Hallucinogen abuse with hallucinogen-induced anxiety disorder |
F16.280 | Hallucinogen dependence with hallucinogen-induced anxiety disorder |
F16.980 | Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder |
F18.180 | Inhalant abuse with inhalant-induced anxiety disorder |
F18.280 | Inhalant dependence with inhalant-induced anxiety disorder |
F18.980 | Inhalant use, unspecified with inhalant-induced anxiety disorder |
F19.180 | Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder |
F19.280 | Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder |
F19.980 | Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder |
F40 | Phobic anxiety disorders |
F40.0 | Agoraphobia |
F40.00 | Agoraphobia, unspecified |
F40.01 | Agoraphobia with panic disorder |
F40.02 | Agoraphobia without panic disorder |
F40.1 | Social phobias |
F40.10 | Social phobia, unspecified |
F40.11 | Social phobia, generalized |
F40.8 | Other phobic anxiety disorders |
F40.9 | Phobic anxiety disorder, unspecified |
F41 | Other anxiety disorders |
F41.0 | Panic disorder [episodic paroxysmal anxiety] |
F41.1 | Generalized anxiety disorder |
F41.3 | Other mixed anxiety disorders |
F41.8 | Other specified anxiety disorders |
F41.9 | Anxiety disorder, unspecified |
F93.0 | Separation anxiety disorder of childhood |
0-9 | A-Z |
---|---|
F06.4 | Anxiety disorder due to known physiological condition |
F10.180 | Alcohol abuse with alcohol-induced anxiety disorder |
F10.23 | Alcohol dependence with withdrawal |
F10.230 | Alcohol dependence with withdrawal, uncomplicated |
F10.231 | Alcohol dependence with withdrawal delirium |
F10.232 | Alcohol dependence with withdrawal with perceptual disturbance |
F10.239 | Alcohol dependence with withdrawal, unspecified |
F10.280 | Alcohol dependence with alcohol-induced anxiety disorder |
F10.980 | Alcohol use, unspecified with alcohol-induced anxiety disorder |
F12.180 | Cannabis abuse with cannabis-induced anxiety disorder |
F12.280 | Cannabis dependence with cannabis-induced anxiety disorder |
F12.980 | Cannabis use, unspecified with anxiety disorder |
F14.180 | Cocaine abuse with cocaine-induced anxiety disorder |
F14.280 | Cocaine dependence with cocaine-induced anxiety disorder |
F14.980 | Cocaine use, unspecified with cocaine-induced anxiety disorder |
F15.180 | Other stimulant abuse with stimulant-induced anxiety disorder |
F15.280 | Other stimulant dependence with stimulant-induced anxiety disorder |
F15.980 | Other stimulant use, unspecified with stimulant-induced anxiety disorder |
F16.180 | Hallucinogen abuse with hallucinogen-induced anxiety disorder |
F16.280 | Hallucinogen dependence with hallucinogen-induced anxiety disorder |
F16.980 | Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder |
F18.180 | Inhalant abuse with inhalant-induced anxiety disorder |
F18.280 | Inhalant dependence with inhalant-induced anxiety disorder |
F18.980 | Inhalant use, unspecified with inhalant-induced anxiety disorder |
F19.180 | Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder |
F19.280 | Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder |
F19.980 | Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder |
F40 | Phobic anxiety disorders |
F40.0 | Agoraphobia |
F40.00 | Agoraphobia, unspecified |
F40.01 | Agoraphobia with panic disorder |
F40.02 | Agoraphobia without panic disorder |
F40.1 | Social phobias |
F40.10 | Social phobia, unspecified |
F40.11 | Social phobia, generalized |
F40.8 | Other phobic anxiety disorders |
F40.9 | Phobic anxiety disorder, unspecified |
F41 | Other anxiety disorders |
F41.0 | Panic disorder [episodic paroxysmal anxiety] |
F41.1 | Generalized anxiety disorder |
F41.3 | Other mixed anxiety disorders |
F41.8 | Other specified anxiety disorders |
F41.9 | Anxiety disorder, unspecified |
F93.0 | Separation anxiety disorder of childhood |